We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$192M
AUM Growth
+$3.31M
Cap. Flow
+$10.5M
Cap. Flow %
5.46%
Top 10 Hldgs %
24.46%
Holding
454
New
344
Increased
40
Reduced
39
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2M
2
GS icon
Goldman Sachs
GS
+$1.47M
3
GSK icon
GSK
GSK
+$1.35M
4
JNJ icon
Johnson & Johnson
JNJ
+$608K
5
TOTL icon
State Street DoubleLine Total Return Tactical ETF
TOTL
+$360K

Top Sells

Rank Stock Value
1
LNCE
Snyders-Lance, Inc.
LNCE
+$3.92M
2
BF.B icon
Brown-Forman Class B
BF.B
+$2.98M
3
WBA
Walgreens Boots Alliance
WBA
+$1.52M
4
GIS icon
General Mills
GIS
+$227K
5
YUM icon
Yum! Brands
YUM
+$225K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.13%
2 Healthcare 17.42%
3 Financials 15.91%
4 Communication Services 8.72%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AYI icon
26
Acuity Brands
AYI
$9.83B
$2.6M 1.36%
18,660
+50
+0.3% +$7.69K
DD icon
27
DuPont de Nemours
DD
$18.5B
$2.55M 1.33%
15,824
-515
-3% -$93.1K
CFFN icon
28
Capitol Federal Financial
CFFN
$1.09B
$2.54M 1.33%
205,809
-13,000
-6% -$169K
DIS icon
29
Walt Disney
DIS
$167B
$2.51M 1.31%
25,007
+150
+0.6% +$15.9K
ABBV icon
30
AbbVie
ABBV
$443B
$2.5M 1.3%
26,404
-1,200
-4% -$132K
XOM icon
31
ExxonMobil
XOM
$644B
$2.47M 1.29%
33,048
+1,351
+4% +$108K
SYY icon
32
Sysco
SYY
$40.8B
$2.31M 1.21%
38,601
-700
-2% -$42.4K
SCHW
33
Charles Schwab
SCHW
$183B
$2.28M 1.19%
43,722
– –
EMR icon
34
Emerson Electric
EMR
$83.9B
$2.28M 1.19%
33,364
-200
-0.6% -$14.2K
FFBC icon
35
First Financial Bancorp
FFBC
$3.55B
$2.23M 1.16%
75,900
-1,600
-2% -$45.1K
PBCT
36
DELISTED
People's United Financial Inc
PBCT
$2.17M 1.13%
116,036
-1,000
-0.9% -$19.4K
MMM icon
37
3M
MMM
$90.9B
$2.16M 1.13%
11,781
– –
ABT icon
38
Abbott
ABT
$183B
$2.15M 1.12%
35,842
– –
MCD icon
39
McDonald's
MCD
$192B
$2.06M 1.07%
13,140
-215
-2% -$35.4K
TD icon
40
Toronto Dominion Bank
TD
$198B
$2.02M 1.05%
35,475
-100
-0.3% -$5.85K
CERN
41
DELISTED
Cerner Corp
CERN
$1.99M 1.04%
34,382
+100
+0.3% +$6.5K
AHL
42
DELISTED
ASPEN Insurance Holding Limited
AHL
$1.94M 1.01%
43,261
+1,700
+4% +$66.7K
GILD icon
43
Gilead Sciences
GILD
$162B
$1.89M 0.99%
+25,100
New +$2M
GSK icon
44
GSK
GSK
$104B
$1.84M 0.96%
37,640
+29,000
+336% +$1.35M
ADP icon
45
Automatic Data Processing
ADP
$106B
$1.78M 0.93%
15,654
-350
-2% -$40.8K
YUM icon
46
Yum! Brands
YUM
$41.8B
$1.76M 0.92%
20,702
-2,750
-12% -$225K
DGX icon
47
Quest Diagnostics
DGX
$25.7B
$1.7M 0.89%
16,975
-650
-4% -$66.6K
JPM icon
48
JPMorgan Chase
JPM
$935B
$1.69M 0.88%
15,409
– –
MSFT icon
49
Microsoft
MSFT
$3.45T
$1.66M 0.87%
18,186
+400
+2% +$36.6K
RTX icon
50
RTX Corp
RTX
$290B
$1.64M 0.86%
20,719
-1,525
-7% -$126K
1
2
3 4 5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Kavar Capital Partners Group's Q1 2018 Portfolio in Review

As of Q1 2018, Kavar Capital Partners Group held 454 positions worth $192M, up 1.8% from $188M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Kavar Capital Partners Group deployed $10.5M of net new capital in Q1 2018, opening 344 new positions and adding to 40 existing holdings. Its largest new stake was Gilead Sciences: 25,100 shares worth $1.89M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $1.52M trimmed.

  • Kavar Capital Partners Group's largest Q1 2018 buy was Gilead Sciences: 25,100 shares worth $1.89M.
  • Kavar Capital Partners Group added most to GSK in Q1 2018, an estimated $1.35M increase.
  • Kavar Capital Partners Group's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $1.52M.
  • Kavar Capital Partners Group fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $3.92M.
  • Kavar Capital Partners Group's ten largest holdings make up 24% of its $192M portfolio in Q1 2018.
  • Kavar Capital Partners Group opened 344 new positions and closed 4 in Q1 2018.
  • Kavar Capital Partners Group's portfolio value rose 1.8% quarter-over-quarter to $192M.

Based on Kavar Capital Partners Group's 13F filing for Q1 2018, filed 16 May 2019.